Skip to content

A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01899313
Enrollment
50
Registered
2013-07-15
Start date
2014-05-31
Completion date
Unknown
Last updated
2014-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amphetamine-Related Disorders

Keywords

methamphetamine dependence, texting, short message service, addiction, amphetamine, outpatient

Brief summary

This Phase I behavior therapy development study seeks to improve treatment outcomes for methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention.

Interventions

BEHAVIORALCBT- based SMS text messaging intervention

Sponsors

California Pacific Medical Center Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English-speaking adults ≥ 18 years who are seeking treatment for MA addiction. * Own a cellular phone with SMS text messaging capability and have an unlimited text messaging plan. * Available to attend CBT therapy groups. * Agreeable to conditions of the study and signed an informed consent form.

Exclusion criteria

* Projected to be unavailable \> 12 hours/day to read and send text messages. * Any medical or psychosocial condition that would preclude safe, useful, or consistent participation,

Design outcomes

Primary

MeasureTime frameDescription
Proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period5 weeksThe primary efficacy measure for this study is the difference in proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period. Urine samples will be analyzed for MA by immunoassay with a cutoff of 1,000 ng/mL.

Countries

United States

Contacts

Primary ContactKathleen Garrison
garrisk@cpmcri.org415-600-3126
Backup ContactReshmi Pal
palrx@cpmcri.org415-600-1652

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026